tirzepatide fda news The says the Zepbound shortage is over. That's rattling the weight loss industry Tirzepatide Wins FDA Approval for

Tiffany Su, uses semaglutide to help our patients get the additional support they need to achieve weight loss success

Blood marker improvements tracked alongside weight loss, providing additional evidence of sustained medication activity

Daniel Drucker led the session with a figure from his recent publication in Diabetes Care that showed established adverse effects, possible adverse effects, and doubtful adverse effects

Management of Ozempic-related skin reactions depends on the severity and nature of the presentation

Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomized, open-label, phase 3b trial